home / stock / lqda / lqda news


LQDA News and Press, Liquidia Technologies Inc. From 01/02/24

Stock Information

Company Name: Liquidia Technologies Inc.
Stock Symbol: LQDA
Market: NASDAQ
Website: liquidia.com

Menu

LQDA LQDA Quote LQDA Short LQDA News LQDA Articles LQDA Message Board
Get LQDA Alerts

News, Short Squeeze, Breakout and More Instantly...

LQDA - Anticompetitive Behavior At United Therapeutics

2024-01-02 10:00:00 ET Summary United Therapeutics Corporation calls itself a "Public Benefit" company. The reality, it is a cynical monopolist about to lose its monopoly. If patent trolling fails, their premium to the entrant could collapse. Disclaimer . ...

LQDA - Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

MORRISVILLE, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, beginning at approxim...

LQDA - Liquidia files for a $200M mixed securities shelf

2023-12-28 16:42:07 ET More on Liquidia Liquidia jumps on win in patent case against United Therapeutics (update) Liquidia prices equity offering For further details see: Liquidia files for a $200M mixed securities shelf

LQDA - Liquidia Gains Edge In PAH Market Following Key Legal Victory

2023-12-21 08:00:00 ET Summary The U.S. Court declares United Therapeutics' PAH treatment patent unpatentable, favoring Liquidia in the market. Liquidia's modest revenue increase and high R&D and G&A expenses lead to a wider net loss. Liquidia has strong short-term liq...

LQDA - U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent)

Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalation Liquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia...

LQDA - CAN, EBON and NDRA among mid-day movers

2023-12-20 13:13:03 ET Gainers: Polished.com ( POL ) +590% . ParaZero Technologies Ltd ( PRZO ) +75% . Liquidia Corp ( LQDA ) +37% . Ebang International Holdings ( EBON ) +35% . ECARX Holdings ( ECX ) +36% . Mawson Infrastruc...

LQDA - Liquidia Corp. (NASDAQ: LQDA) Leading the Way in Wednesday Trading Based on Percentage Gain

Liquidia Corporation (NASDAQ: LQDA) is one of today's top gainers. The company's shares have moved 0.48% on the day to $6.23. Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product...

LQDA - 2024 - Liquidia, Burford, And Roivant

2023-12-20 12:00:32 ET Summary Liquidia Corporation is worth at least $15 in a win. Roivant Sciences is worth at least $12 per share. Burford Capital Limited is worth at least $20 per share. Value & Event Driven Investing I recently spoke for a half an hour a...

LQDA - Liquidia jumps on win in patent case against United Therapeutics

2023-12-20 09:54:22 ET More on Liquidia Liquidia Corporation (LQDA) Q3 2023 Earnings Call Transcript Liquidia prices equity offering Liquidia gains as court sets December date for hearing in patent dispute Seeking Alpha’s Quant Rating on Liquidia ...

LQDA - Liquidia director buys stock worth $2M

2023-12-19 06:56:37 ET More on Liquidia Liquidia prices equity offering Liquidia gains as court sets December date for hearing in patent dispute For further details see: Liquidia director buys stock worth $2M

Previous 10 Next 10